Bicara Therapeutics (BCAX) Cash from Financing Activities (2023 - 2026)
Bicara Therapeutics' Cash from Financing Activities came in at $2.33 million for Q2 2026, compared with $135,000 a year earlier and down 98.6% from the prior quarter.
Powered by 
Analysis
Bicara Therapeutics (BCAX) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bicara Therapeutics reported Cash from Financing Activities of $197.34 million, down 40.9% year-over-year; for FY2025, it came in at $32.26 million, down 90.3% from FY2024.
- Going back by year, Cash from Financing Activities was $334.03 million in FY2024 (+22.6%) and $272.5 million in FY2023.
- The five-year range for quarterly Cash from Financing Activities is -$975,000 (Q4 2024) to $334.14 million (Q3 2024).
- Business Quant data shows BCAX's Cash from Financing Activities at $163.35 million (Q1 2026), $31.23 million (Q4 2025) and $436,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Bicara Therapeutics | 1.23 Bn | 1.23 Bn | - | 2.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.33 Mn |
| Mar 31, 2026 | 163.35 Mn |
| Dec 31, 2025 | 31.23 Mn |
| Sep 30, 2025 | 436,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Mar 31, 2025 | 460,000.00 |
| Dec 31, 2024 | -975,000.00 |
| Sep 30, 2024 | 334.14 Mn |
| Jun 30, 2024 | 734,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Dec 31, 2023 | 194.70 Mn |
API Access
Bicara Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BCAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BCAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BCAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();